Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger
Provided By GlobeNewswire
Last update: Nov 13, 2025
Strategic transaction supports the advancement of Decoy’s rapid computational design and manufacturing of innovative peptide conjugate therapeutics through its IMP3ACT™ platform
Read more at globenewswire.com0.83
+0.01 (+0.61%)
Find more stocks in the Stock Screener
SLRX Latest News and Analysis
